Clinical trials
Cardiomyopathies trials in the United States with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
51 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2005 | 4 |
| 2006 | 2 |
| 2007 | 1 |
| 2009 | 3 |
| 2010 | 1 |
| 2011 | 2 |
| 2012 | 4 |
| 2013 | 2 |
| 2014 | 6 |
| 2015 | 3 |
| 2016 | 5 |
| 2017 | 1 |
| 2018 | 2 |
| 2020 | 1 |
| 2021 | 4 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 30 |
| Terminated | 8 |
| Recruiting | 5 |
| Withdrawn | 5 |
| Unknown status | 2 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Abbott Medical Devices | 4 |
| University of California, San Diego | 3 |
| Ancora Heart, Inc. | 2 |
| Emory University | 2 |
| University of Pittsburgh | 2 |
| Berlin Heart, Inc | 1 |
| BioVentrix | 1 |
| Biotronik, Inc. | 1 |
| Brigham and Women's Hospital | 1 |
| Cardiovascular Institute of the South Clinical Research Corporation | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cardiomyopathies | 51 |
| Heart Failure | 24 |
| Heart Diseases | 5 |
| Cardiovascular Diseases | 4 |
| Coronary Artery Disease | 4 |
| Ventricular Dysfunction | 4 |
| Arrhythmias, Cardiac | 3 |
| Bundle-Branch Block | 2 |
| Cardiomyopathy, Hypertrophic | 2 |
| Death, Sudden, Cardiac | 2 |
Trials
Showing 1 to 25 of 51. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.